| Proteasome |
1.79 |
1.76e-1 |
44/46 (95.65%) |
PSMB5;PSMC3;PSMC4;...
|
| Thiamine metabolism |
1.72 |
1.60e-1 |
12/15 (80%) |
TPK1;AK2;ALPL;...
|
| Circadian rhythm |
1.71 |
1.12e-1 |
26/31 (83.87%) |
PER2;PRKAA1;PER3;...
|
| Spliceosome |
1.63 |
1.76e-1 |
101/150 (67.33%) |
HSPA1A;HSPA8;SNU13;...
|
| DNA replication |
1.60 |
2.10e-1 |
34/36 (94.44%) |
RFC5;MCM6;MCM5;...
|
| Propanoate metabolism |
1.58 |
2.02e-1 |
30/34 (88.24%) |
PCCB;SUCLG2;ACAT1;...
|
| Parkinson disease |
1.57 |
1.88e-1 |
176/249 (70.68%) |
DAXX;PSMB5;UCHL1;...
|
| Alanine, aspartate and glutamate metabolism |
1.56 |
1.89e-1 |
27/37 (72.97%) |
GLUD2;ASNS;GLS2;...
|
| Sulfur relay system |
1.54 |
1.99e-1 |
5/8 (62.5%) |
TST;MOCS2
|
| Amino sugar and nucleotide sugar metabolism |
1.52 |
2.14e-1 |
38/48 (79.17%) |
UAP1;GMDS;UGP2;...
|
| Proximal tubule bicarbonate reclamation |
1.52 |
1.95e-1 |
21/23 (91.3%) |
CA2;ATP1A1;GLUD2;...
|
| Malaria |
1.50 |
2.10e-1 |
44/50 (88%) |
TLR4;COMP;TLR2;...
|
| Amyotrophic lateral sclerosis |
1.48 |
2.36e-1 |
267/364 (73.35%) |
DAXX;SEH1L;GPX7;...
|
| Staphylococcus aureus infection |
1.42 |
3.33e-1 |
72/95 (75.79%) |
KRT19;KRT17;KRT15;...
|
| Arginine biosynthesis |
1.35 |
4.43e-1 |
17/22 (77.27%) |
GLUD2;GLS2;GLUL;...
|
| Protein export |
1.33 |
4.48e-1 |
17/23 (73.91%) |
OXA1L;SRP54;SRP14;...
|
| Starch and sucrose metabolism |
1.33 |
4.35e-1 |
25/36 (69.44%) |
UGP2;GBA3;GYG2;...
|
| Protein processing in endoplasmic reticulum |
1.33 |
4.16e-1 |
127/171 (74.27%) |
DAD1;HSPH1;HSPA1A;...
|
| Linoleic acid metabolism |
1.31 |
4.34e-1 |
21/29 (72.41%) |
PLAAT3;PLA2G4C;CYP2C9;...
|
| Neutrophil extracellular trap formation |
1.31 |
4.22e-1 |
101/189 (53.44%) |
HAT1;TLR4;TLR2;...
|
| Prion disease |
1.31 |
4.08e-1 |
209/273 (76.56%) |
PSMB5;ATP5MC2;COX7A1;...
|
| Transcriptional misregulation in cancer |
1.30 |
4.09e-1 |
158/192 (82.29%) |
LMO2;MLF1;ERG;...
|
| Basal transcription factors |
1.30 |
3.95e-1 |
37/45 (82.22%) |
GTF2E1;TAF5;TAF10;...
|
| Type II diabetes mellitus |
1.29 |
4.15e-1 |
42/46 (91.3%) |
IRS2;INSR;CACNA1A;...
|
| Retinol metabolism |
1.29 |
4.22e-1 |
41/68 (60.29%) |
ALDH1A3;CYP26B1;DHRS9;...
|
| Cysteine and methionine metabolism |
1.27 |
4.44e-1 |
43/50 (86%) |
CBS;TST;BCAT1;...
|
| Pathways of neurodegeneration |
1.27 |
4.37e-1 |
354/475 (74.53%) |
DAXX;GPX7;PSMB5;...
|
| Mismatch repair |
1.27 |
4.28e-1 |
22/23 (95.65%) |
RFC5;MSH2;MLH1;...
|
| Nitrogen metabolism |
1.27 |
4.23e-1 |
16/17 (94.12%) |
CA2;GLUD2;GLUL;...
|
| Bile secretion |
1.26 |
4.37e-1 |
68/90 (75.56%) |
CA2;ATP1A1;UGT2B15;...
|
| Human cytomegalovirus infection |
-1.32 |
4.33e-1 |
201/225 (89.33%) |
GNG10;RPS6KB1;CDKN1A;...
|
| JAK-STAT signaling pathway |
-1.33 |
4.39e-1 |
146/162 (90.12%) |
IL5;IL5RA;PIK3R2;...
|
| Arrhythmogenic right ventricular cardiomyopathy |
-1.33 |
4.48e-1 |
70/77 (90.91%) |
SGCG;ACTB;LAMA2;...
|
| Yersinia infection |
-1.34 |
4.45e-1 |
120/137 (87.59%) |
ZAP70;MEFV;GNAQ;...
|
| Human papillomavirus infection |
-1.34 |
4.56e-1 |
284/331 (85.8%) |
PPP2R5D;PTEN;RPS6KB1;...
|
| TNF signaling pathway |
-1.36 |
4.13e-1 |
103/112 (91.96%) |
PIK3CD;TRAF2;TNFRSF1A;...
|
| Autoimmune thyroid disease |
-1.36 |
4.23e-1 |
46/53 (86.79%) |
HLA-DMB;IFNA4;CTLA4;...
|
| Non-small cell lung cancer |
-1.36 |
4.39e-1 |
70/72 (97.22%) |
CDKN1A;RXRA;GADD45G;...
|
| Prostate cancer |
-1.37 |
4.53e-1 |
93/97 (95.88%) |
PLAU;PIK3CD;CCND1;...
|
| Breast cancer |
-1.38 |
4.46e-1 |
119/147 (80.95%) |
FGF9;DVL2;PTEN;...
|
| Dilated cardiomyopathy |
-1.39 |
4.49e-1 |
86/96 (89.58%) |
SLC8A1;ADCY1;SGCG;...
|
| Intestinal immune network for IgA production |
-1.42 |
3.60e-1 |
38/48 (79.17%) |
CCR9;HLA-DMB;IL5;...
|
| Endometrial cancer |
-1.43 |
3.59e-1 |
56/58 (96.55%) |
MAP2K2;PIK3R2;BAD;...
|
| NOD-like receptor signaling pathway |
-1.43 |
3.80e-1 |
145/181 (80.11%) |
BIRC2;MEFV;TNFAIP3;...
|
| Rheumatoid arthritis |
-1.43 |
4.00e-1 |
78/93 (83.87%) |
MMP3;IL18;ITGB2;...
|
| Shigellosis |
-1.45 |
3.72e-1 |
180/246 (73.17%) |
RRAGA;CBX3;FOXO4;...
|
| Vibrio cholerae infection |
-1.46 |
3.58e-1 |
44/50 (88%) |
PRKACA;ATP6V1F;CFTR;...
|
| Thyroid hormone signaling pathway |
-1.46 |
3.75e-1 |
112/121 (92.56%) |
RXRA;PFKM;ATP1A2;...
|
| GnRH secretion |
-1.47 |
3.71e-1 |
60/64 (93.75%) |
PIK3CD;PLCB4;GABBR2;...
|
| Kaposi sarcoma-associated herpesvirus infection |
-1.48 |
3.88e-1 |
172/193 (89.12%) |
CDKN1A;IRF9;HLA-G;...
|
| Amoebiasis |
-1.50 |
3.51e-1 |
99/102 (97.06%) |
IL12A;GNAQ;CD1E;...
|
| Relaxin signaling pathway |
-1.50 |
3.83e-1 |
114/129 (88.37%) |
PIK3CD;MMP1;PLCB4;...
|
| Glycerolipid metabolism |
-1.55 |
2.83e-1 |
44/61 (72.13%) |
DGKG;AGPAT1;AGPAT2;...
|
| Apoptosis |
-1.57 |
2.83e-1 |
126/168 (75%) |
BCL2A1;TP53AIP1;GADD45G;...
|
| Prolactin signaling pathway |
-1.57 |
3.14e-1 |
66/70 (94.29%) |
PIK3CD;CCND1;GRB2;...
|
| Steroid biosynthesis |
-1.61 |
2.67e-1 |
19/20 (95%) |
SOAT1;CYP51A1;CYP24A1;...
|
| ECM-receptor interaction |
-1.63 |
2.64e-1 |
80/88 (90.91%) |
LAMC3;CD47;COL6A3;...
|
| Other glycan degradation |
-1.63 |
3.44e-1 |
13/18 (72.22%) |
HEXB;MANBA;MAN2C1;...
|
| Lysosome |
-1.72 |
2.05e-1 |
115/128 (89.84%) |
CTSO;M6PR;PSAP;...
|
| Small cell lung cancer |
-1.82 |
1.29e-1 |
90/92 (97.83%) |
BIRC2;PTEN;CDKN1A;...
|
